The Company leverage its experience and knowledge in powering the human immune system to develop and market products that target serious medical conditions in the areas of transplantation, infectious disease and hematology/oncology.
The best Bull and Bear pitches based on recency and number of recommendations.
This is a rather uninspiring play on a busted biopharma. After the phase III trials of NicVAX failed last year, just about everybody lost interest in Nabi. The company has substantial cash but zero pipeline and in April they agreed to a reverse… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about NABI.DL.
Find the members with the highest scoring picks in NABI.DL.
Reallynow222 (85.34) Score: +520.58
The Score Leader is the player with the highest score across all their picks in NABI.DL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| veteranshipper | < 20 | 9/2/2020 |
|
5Y | $10.80 | 0% | +19.57% | -19.57 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
